Literature DB >> 16425248

Apoptosis as an instrument in cardiovascular development.

Robert E Poelmann1, Adriana C Gittenberger-de Groot.   

Abstract

Cell death as a phenomenon in embryonic development was first described over 100 years ago. Approximately 30 years ago the process was named apoptosis, and its involvement is now recognized in many life processes, in virtually every animal species, and from fertilization to the death of an organism. In cardiovascular development, it coincides with major developmental processes in specific time windows. Both intrinsic (controlled by mitochondrial activity) and extrinsic (starting with death receptors) apoptotic pathways co-regulate developmental mechanisms. During cardiac development, many cell populations are recruited to the heart, where they differentiate into cardiomyocytes, fibroblasts, smooth muscle cells, endocardial and endothelial cells lining the inner surfaces, and epicardial cells lining the outer contours. In particular, neural crest-derived cell populations, which migrate to specific locations in the heart, are prone to apoptosis. During the complex geometric changes that occur in the primary heart tube and connected vessel segments, proper interaction of the respective cell populations guarantees the ensuing steps of differentiation. Growth factors, including endothelin, VEGF, and TGF-beta, as well as other factors, such as FasL, play dominant roles in these phases. Transgenic and knockout studies have provided strong evidence for aberrant patterns of apoptosis resulting in congenital malformations and syndromic malformations, including septation anomalies, interrupted aortic arch segments, coronary anomalies, and DiGeorge syndrome. Embryonic remodeling of the arterial system, including the coronary arteries, is accompanied by apoptosis patterns, the disruption of which results in severe malformations. It is interesting to note that hemodynamic factors, such as flow-driven shear stress, regulate the expression of genes that are important for signaling molecules such as endothelin and NO-synthase. In general, high shear stress protects against apoptosis, thus preventing the onset of disease processes in the fully-grown vasculature, and regulating the remodeling of the vascular system in the embryo.

Entities:  

Mesh:

Year:  2005        PMID: 16425248     DOI: 10.1002/bdrc.20058

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  12 in total

Review 1.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 2.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

3.  Rbm24, a target of p53, is necessary for proper expression of p53 and heart development.

Authors:  Min Zhang; Yanhong Zhang; Enshun Xu; Shakur Mohibi; Danielle Michelle de Anda; Yuqian Jiang; Jin Zhang; Xinbin Chen
Journal:  Cell Death Differ       Date:  2018-01-22       Impact factor: 15.828

4.  Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure.

Authors:  Femke Zwerts; Florea Lupu; Astrid De Vriese; Saskia Pollefeyt; Lieve Moons; Rachel A Altura; Yuying Jiang; Patrick H Maxwell; Peter Hill; Hideyasu Oh; Claus Rieker; Désiré Collen; Simon J Conway; Edward M Conway
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

5.  Rare copy number variants in patients with congenital conotruncal heart defects.

Authors:  Hongbo M Xie; Petra Werner; Dwight Stambolian; Joan E Bailey-Wilson; Hakon Hakonarson; Peter S White; Deanne M Taylor; Elizabeth Goldmuntz
Journal:  Birth Defects Res       Date:  2017-02-13       Impact factor: 2.344

Review 6.  Histology atlas of the developing mouse heart with emphasis on E11.5 to E18.5.

Authors:  Saija M Savolainen; Julie F Foley; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2009-04-09       Impact factor: 1.902

7.  Induction of apoptosis and inhibition of cell growth by tbx5 knockdown contribute to dysmorphogenesis in Zebrafish embryos.

Authors:  Jenher Lu; Tzuchun Tsai; Sielin Choo; Shuyu Yeh; Renbing Tang; Anhang Yang; Hsinyu Lee; Jennkan Lu
Journal:  J Biomed Sci       Date:  2011-10-08       Impact factor: 8.410

Review 8.  Congenital coronary arteries anomalies: review of the literature and multidetector computed tomography (MDCT)-appearance.

Authors:  M Montaudon; V Latrabe; X Iriart; P Caix; F Laurent
Journal:  Surg Radiol Anat       Date:  2007-06-12       Impact factor: 1.354

9.  Mutation of the zebrafish nucleoporin elys sensitizes tissue progenitors to replication stress.

Authors:  Gangarao Davuluri; Weilong Gong; Shamila Yusuff; Kristin Lorent; Manimegalai Muthumani; Amy C Dolan; Michael Pack
Journal:  PLoS Genet       Date:  2008-10-31       Impact factor: 5.917

10.  N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes.

Authors:  Hoda Moazzen; Xiangru Lu; Noelle L Ma; Thomas J Velenosi; Brad L Urquhart; Lambertus J Wisse; Adriana C Gittenberger-de Groot; Qingping Feng
Journal:  Cardiovasc Diabetol       Date:  2014-02-18       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.